We previously reported that naringin (NRG) protects cardiomyocytes against high glucose (HG)-induced injuries by inhibiting the MAPK pathway. The aim of this study was to test the hypothesis that NRG prevents cardiomyocytes from hyperglycemia-induced insult through the inhibition of the nuclear factor kappa B (NF-κB) pathway and the upregulation of ATP-sensitive K + (K ATP ) channels. Our results showed that exposure of cardiomyocytes to HG for 24 h markedly induced injuries, as evidenced by a decrease in cell viability and oxidative stress, and increases in apoptotic cells as well as the dissipation of mitochondrial membrane potential (MMP). These injuries were markedly attenuated by the pretreatment of cells with either NRG or pyrrolidine dithiocarbamate (PDTC) before exposure to HG. Furthermore, in streptozotocin (STZ)-induced diabetic rats and in HG-induced cardiomyocytes, the expression levels of caspase-3, bax and phosphorylated (p)-NF-κB p65 were increased. The increased protein levels were ameliorated by pretreatment with both NRG and PDTC. However, the expression levels of bcl-2 and K ATP and superoxide dismutase (SOD) activity were decreased by hyperglycemia; the expression level of Nox4 and the ADP/ATP ratio were increased by hyperglycemia. These hyperglycemia-induced indexes were inhibited by the pretreatment of cardiomyocytes with NRG or PDTC. In addition, in STZ-induced diabetic rats, we also observed that NRG or PDTC contributed to protecting mitochondrial injury and myocardium damage. This study demonstrated that NRG protects cardiomyocytes against hyperglycemia-induced injury by upregulating K ATP channels in vitro and inhibiting the NF-κB pathway in vivo and in vitro.
Introduction
Currently, statistical analysis shows that diabetes mellitus (DM) affects approximately 387 million people globally and is projected to increase two-fold in the next 25 years (Huang et al. 2009 ). As a disease of epidemic proportions, DM damages every organ in the human body by causing serious microvascular and macrovascular diseases.
Diabetic cardiomyopathy (DCM), one of the most prevalent cardiovascular complications and a major cause of death of DM, causes congestive heart failure (Lakdawala et al. 2013 , Camafort 2015 and sudden death in young people (Ellis & Di Salvo 2007) . DCM is different from hypertensive cardiomyopathy and is a unique cardiovascular disease due to hyperglycemia-induced oxidative stress (Privratsky et al. 2003 , Kamalakkannan & Prince 2006 , Saandeep et al. 2009 , Murali et al. 2013 , Peake et al. 2013 , Umbarkar et al. 2015 , inflammation (Marfella et al. 2003 , Di et al. 2005 , Venkatachalam et al. 2008 , cardiac fibrosis (Fonarow & Srikanthan 2006) , myocardial apoptosis (Fonarow & Srikanthan 2006 ) and mitochondrial damage (Boudina et al. 2007 , Ceriello 2008 .
The activation of nuclear factor kappa B (NF-κB), which can control the molecular processes within cardiomyocytes, contributes to many heart diseases, such as myocardial hypertrophy and coronary artery disease. Normally, NF-κB is an IκB (inhibitor of NF-κB)-bound complex in the cytoplasm and consists of homodimers or heterodimers mainly comprising the following subunits: RelA (p65), C-Rel, NF-κB1 (P50/P105), RelB and NF-κB2 (P52/P100). The NF-κB pathway may be activated by various stimuli, including growth factors, lymphokines, pharmacological agents, cytokines and stress. Upon stimulation, NF-κB is activated and released from its IκB-bound complex and translocates into the nucleus from the cytoplasm. This molecular process allows NF-κB (p65) to bind to κB sequences and alter the expression of various target genes (Werner et al. 2005) . The same pathophysiologic processes occur in hyperglycemiainduced cardiomyocyte injuries. An increase of NF-κB activity in high glucose (HG)-induced cardiomyocytes (Min et al. 2009 , Tsai et al. 2012 and in streptozotocin (STZ)-induced diabetic rats (Chen et al. 2003 , Mariappan et al. 2010 ) has been demonstrated. By binding to κB sequences and altering the expression of various target genes, the NF-κB pathway is involved in related processes, including oxidative stress (Valen et al. 2001 , Fang et al. 2004 , Eisner et al. 2006 , inflammation (Fang et al. 2004 , Westermann et al. 2007a ,b, Arkan & Greten 2011 , mitochondrial damage (Guleria et al. 2013) , apoptosis (Guleria et al. 2013) , endothelial dysfunction, hypertrophy and cardiac fibrosis (van Heerebeek et al. 2008) in DCM. Thus, NF-κB plays a key role in the development of DCM. However, the role of NF-κB in hyperglycemia-induced hypertrophy and cardiac fibrosis in the cardioprotective action of NRG remains unclear.
Another important molecule is the K ATP channel due to its cardioprotection in various types of cardiovascular diseases (Badalzadeh et al. 2014 , 2015 , Waza et al. 2014 . In addition, accumulating evidence has revealed that DM has been associated with dysfunction of the cardiovascular K ATP channels (Weintraub 2003) . Hyperglycemia and DM impair vasodilation mediated by K ATP channels in human vascular smooth muscle cells (Miura et al. 2003 , Kinoshita et al. 2004 , Kinoshita et al. 2006 . Furthermore, a recent study shows that diabetes reduces mitoK ATP expression and function. These changes in mitoK ATP may provide an opportunity to understand the mechanisms that lead to DCM and the loss of cardioprotective mechanisms in the diabetic heart (Fancher et al. 2013) . However, the roles of both sarcolemmal K ATP channels and mitochondrial K ATP channels in HG-induced cardiomyocyte injury, particularly the cardioprotective role of NRG, remain unclear.
NRG is recognized by more and more people due to its comprehensive physiological and pharmacological effects, including antioxidant (Jung et al. 2003 , Jeon et al. 2004 , Rajadurai & Prince 2007 , Bodas et al. 2011 , Jain & Parmar 2011 , Mahmoud et al. 2012 , antihypercholesterolemic (Jung et al. 2003 , Kim et al. 2004 , Jung et al. 2006 , anti-inflammatory (Jung et al. 2003 , Bodas et al. 2011 , Mahmoud et al. 2012 , cardioprotection (Huang et al. 2013 , Chen et al. 2014a and anti-apoptotic effects (Jagetia et al. 2003 , Kanno et al. 2003 . Furthermore, Huang et al. (2013) and Chen et al. (2014a,b) demonstrated that NRG inhibited the MAPK pathway (p38 MAPK, ERK1/2 and JNK) in HG-induced injuries in H9c2 cardiac cells. In recent years, many studies have shown that NRG could regulate glycolipid metabolism. Our earlier report clarified that NRG could protect against cardiomyocyte dysfunction in diabetic hearts by inhibiting NF-κB . However, the underlying mechanisms are still unclear.
Materials and methods

Chemicals
Naringin
(NRG), 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine iodide (JC-1), Hoechst 33258, STZ and pyrrolidine dithiocarbamate (PDTC, a specific inhibitor of NF-κB pathway) were purchased from Sigma-Aldrich. Diazoxide (DZ, a mitochondrial K ATP channel opener), pinacidil (Pin, a non-selective K ATP channel opener), 5-hydroxydecanoic acid (5-HD, a mitochondrial K ATP channel blocker) and glibenclamide (Gli, a non-selective K ATP channel blocker) were purchased from Cayman Chemical. The cell counter kit-8 (CCK-8) was supplied by Dojindo Lab (Kumamoto, Japan). Fetal bovine serum (FBS) and DMEM medium were obtained from Gibco BRL; anti-kir6.1 (R-14) was purchased from Santa Cruz Biotechnology; anti-p-NF-κB p65 antibody, anti-p65 antibody anticaspase-3 antibody, anti-bax antibody and anti-bcl-2 antibody were purchased from Cell Signaling Technology; HRPconjugated secondary antibody and BCA protein assay kit were obtained from KangChen Bio-tech, Inc. (Shanghai, China). Enhanced chemiluminescence (ECL) solution was purchased from KeyGen Biotech (Nanjing, China).
Experimental animals and treatment
The experimental protocol was approved by the Institutional Animal Care and Ethical Committee of Guangdong Medical College (No: 01/022/12). Sixty male Sprague-Dawley (SD) rats weighing 200 ± 10 g (7 weeks in age) were used in this experiment. Rats were housed under controlled temperature (20 ± 2°C) and lighting conditions (07:00 to 19:00 h, 12 h light:12 h darkness), with food and water available ad libitum. The high-sugar and high-fat diet comprised 66.6% basic rat chow, 20% sucrose, 10% lard, 3% egg yolk and 0.4% cholesterol. Animals were randomly divided into six groups (n = 10 in each group): (i) the control group (healthy rats, n = 10, mortality rate 0%): the rats were given normal saline; (ii) the STZ group (healthy rats, n = 9, mortality rate 10%): the rats were fed a high-sugar and high-fat diet for 6 weeks and then were administered an intraperitoneal injection of 30 mg/kg/day STZ; (iii) the STZ + low-dose NRG group (STZ + L-NRG, healthy rats, n = 9, mortality rate 10%, NRG = 25 mg/kg): the rats were fed a high-sugar and high-fat diet for 6 weeks and then were administered an intraperitoneal injection of 30 mg/kg/day STZ to establish the diabetic model, followed by an intraperitoneal injection of 25 mg/kg/day NRG; (iv) the STZ + middle dose NRG group (STZ + M-NRG, healthy rats, n = 10, mortality rate 0%, NRG = 50 mg/kg): the rats were fed a high-sugar and high-fat diet for 6 weeks and then were administered an intraperitoneal injection of 30 mg/kg/day STZ to establish the diabetic model, followed by an intraperitoneal injection of 50 mg/kg/day NRG; (v) the STZ + high dose NRG group (STZ + H-NRG, healthy rats, n = 10, mortality rate 0%, NRG = 100 mg/kg): the rats were fed a high-sugar and high-fat diet for 6 weeks and then were administered an intraperitoneal injection of 30 mg/kg/day STZ to establish the diabetic model, followed by an intraperitoneal injection of 100 mg/kg/day NRG; and (vi) the STZ + PDTC group (healthy rats, n = 10, mortality rate 0%): the rats were fed a high-sugar and high-fat diet for 6 weeks and then were administered an intraperitoneal injection of 30 mg/kg/day STZ to establish the diabetic model, followed by an intraperitoneal injection of 100 mg/kg/day PDTC. After 6 weeks, the animals were killed (at the end of the experiments, the body weight of the various groups was recorded and the animals were anesthetized by 5% chloral hydrate) and the heart weight index determination of the ventricular myocardium was calculated. Concentration of the PDTC solution was 5 mg/mL; concentration of the NRG solution was 2 μg/mL and concentration of the STZ solution was 10 mg/mL. Our data showed that NRG (doses from 25 to 100 mg/kg/day) and 100 mg/kg/day PDTC were non-poisonous, and the data from the NRG group and PDTC group are not shown in this paper.
H9c2 cardiac cells culture and treatment
The H9c2 cardiac cells, a rat cardiac myoblasts cell line, were obtained from Sun Yat-sen University Experimental Animal Center (Guangzhou, Guangdong, China). The cells were grown in DMEM medium supplemented with 10% FBS under an atmosphere of 5% CO 2 at 37°C and 95% air.
To investigate the role of NF-κB pathway and K ATP channels in HG-induced cardiomyocyte injury, H9c2 cells were preconditioned with 100 µM PDTC (a specific inhibitor of NF-κB pathway) or 100 μM DZ or 50 μM Pin for 30 min before exposure to 35 mM glucose for 24 h. To explore the protective effects of NRG on HG-induced injury, the H9c2 cells were preconditioned with 80 µM NRG for 2 h before exposure to 35 mM glucose for 24 h. To further determine whether the protective effects of NRG were associated with the activation of K ATP channels, the cells were preconditioned with 100 µM 5-HD or 1 mM Gli for 30 min before exposure to NRG treatment and 35 mM glucose for 24 h.
Cell viability assay
H9c2 cardiac cells were cultured in 96-well plates at a concentration of 1 × 10 4 /mL, the CCK-8 assay was employed to measure the cell viability of H9c2 cells. After the indicated treatments, 10 µL of CCK-8 solution at a 1/10 dilution was added to every well and then the plate was incubated for 3 h in the incubator. Absorbance at 450 nm was measured with a microplate reader (Molecular Devices, Sunnyvale, CA, USA). The means of the optical density (OD) of 4 wells in the indicated groups were used to calculate the percentage of cell viability according to the following formula: cell viability (%) = (OD treatment group/OD control group) × 100%. The above experiment was repeated five times.
Hoechst 33258 nuclear staining for assessment of apoptosis
Apoptotic cell death was measured by the Hoechst 33258 staining followed by photofluorography. In brief, H9c2 cardiac cells were plated in 35 mm dishes at a density of 1 × 10 6 cells/well, the cells were preconditioned with 80 µM NRG for 2 h or 100 µM PDTC for 30 min, and subsequently exposed to 35 mM glucose for 24 h. At the end of the different treatments, H9c2 cells were cultured with 4% paraformaldehyde in 0.1 mol/L PBS (pH 7.4) for 10 min. Then the slides were washed three times with PBS; after staining with 5 mg/mL Hoechst 33258 for 30 min, H9c2 cells were washed three times with PBS, PBS was discarded and the cells were air dried. Finally, the cells were visualized under fluorescence microscope (BX50-FLA, Olympus). Viable H9c2 cells displayed a uniform blue fluorescence throughout the nucleus and normal nuclear size; however, apoptotic H9c2 cells showed condensed, fractured or distorted nuclei. The experiment was repeated three times.
Measurement of the mitochondrial membrane potential
The mitochondrial membrane potential (MMP) was obtained using a fluorescent dye, JC-1, a cell-permeable cationic dye that preferentially enters mitochondria based on the highly negative MMP. Depolarization of MMP results in a loss of MMP from the mitochondria and a decrease in green fluorescence. H9c2 cells were cultured in a slide with DMEM at a density of 1 × 10 6 cells/well. After the indicated treatments, the slides were washed three times with PBS; then the cells were incubated with 1 mg/L Rh123 at 37°C for 30 min in the incubator, washed briefly three times with PBS and air-dried. Then fluorescence was measured over the hold field of vision by using fluorescent microscope connected to an imaging system (BX50-FLA). The mean fluorescence intensity (MFI) of JC-1 from three random fields was analyzed using the ImageJ 1.47i software, the MFI was taken as an index of the levels of MMP. The experiment was repeated three times. 
Western blot assay for expressions of protein
After the indicated treatments, a small quantity of myocardial tissue of each group of rat was cut into fragments, and then homogenized with radioimmunoprecipitation assay (RIPA) buffer for protein extraction. Following the centrifugation of the lysates (14,000 g for 15 min at 4°C), the supernatants were quantified using a bicinchoninic acid protein assay. H9c2 cardiac cells were harvested and lysed with cell lysis solution at 4°C for 30 min. The total proteins were quantified using the BCA protein assay kit. Loading buffer was added to cytosolic extracts; after boiling for about 5 min, the same amounts of supernatant from each sample were fractionated by 10% SDS-PAGE; and then the total proteins were transferred into PVDF membranes. The membranes were blocked with 5% fatfree milk for 60 min in fresh blocking buffer (0.1% Tween 20 in TBS-T, and incubated with anticaspase-3 antibody (1:1000 dilution), anti-bcl-2 antibody (1:1000 dilution), anti-bax antibody (1:1000 dilution), anti-p65 antibody (1:1000 dilution), anti-p-NF-κB antibody (1:1000 dilution) and anti-Nox4 antibody (1:1000 dilution) in freshly prepared TBS-T with 3% free-fat milk overnight with gentle agitation at 4°C. Membranes were washed for three times with TBS-T and successively incubated with horseradish peroxidase (HRP)-conjugated goat antirabbit secondary antibody (1:2500 dilution) in TBS-T with 3% fat-free milk for 90 min at room temperature. Then the membranes were washed three times with TBS-T for 5 min. The immunoreactive signals were subsequently visualized by using enhanced chemiluminescence (ECL) detection. In order to quantify the protein expression, the X-ray films were scanned and analyzed with ImageJ 1.47i software. The experiment was repeated three times.
Real-time PCR
Real-time PCR was carried out in 200 μL Eppendorf (EP) tubes without bacteria and enzyme. Approximately 2 μg cell total RNA, 1 μL oligo duplicated T, 1 μL diethylnitrophenyl thiophosphate and diethylpyrocarbonate liquid were placed into PCR system for reaction at 65°C for 5 min. Once the reaction ended, the liquid was taken out and put on ice. Then 4 μL 5× first strand buffer and 2 μL dl-dithiothreitol were successively added for reaction at 37°C for 2 min; after that 1 μL reverse transcriptase was added to every tube for reaction at 37°C for 50 min and then at 70°C for 15 min.
Examination of intracellular reactive oxygen species generation
Intracellular reactive oxygen species (ROS) generation was tested by the oxidative conversion of cell-permeable oxidation of 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) to fluorescent DCF. H9c2 cells were cultured in a slide. With the different treatments, the slides were washed three times; 10 µM DCFH-DA solution in Figure 1 Naringin reduces hyperglycemia-induced activation of NF-κB p65 in H9c2 cells and in STZ-induced diabetic rats. (A and B) H9c2 cells were exposed to 35 mM glucose for the indicated times (30, 60, 90, 120, 150 and 180 min) to test the effects of HG on NF-ΚB p65 phosphorylation, and then H9c2 cells were exposed to 35 mM glucose for 24 h in the absence or presence of pretreatment with 80 μM NRG for 2 h before exposure to HG. Cytoplasm and nuclear extracts were extracted. The expression level of NF-κB p65 was also measured in STZ-induced diabetic rats. The expression of p65 was analyzed by Western blotting analysis. (B, C, E, G, H, K and M) Densitometric analysis of the KATP channels expression levels in (A, D, F, J and L) with ImageJ 1.47i software. (C, I and N) The p65 mRAN were tested. Data are shown as the mean ± s.e.m. (n = 3). **P < 0.01 vs with the control group; ++ P < 0.01 vs with the HG-treated group and the STZ group, respectively. cyto, cytoplasm; HG, high glucose, 35 mM glucose; NRG, naringin; nuc, nuclear.
serum-free medium was added to the slides, and then H9c2 cells were incubated at 37°C for 30 min in the incubator. The slides were washed five times with PBS, and DCF fluorescence was measured over the entire field of vision using a fluorescence microscope connected to an imaging system (BX50-FLA). The MFI of ROS from five random fields was measured using ImageJ 1.47i software and the MFI was used as an index of the amount of ROS. The experiment was repeated three times.
Measurement of SOD activity
Superoxide dismutase (SOD) activity was tested by using SOD assay kit. After the indicated treatments, cells were washed using PBS and lysed in ice-cold 0.1 M Tris-HCl (pH 7.4) containing 0.5% Triton, 5 mM β-mercaptoethanol and 0.1 mg/mL phenylmethylsulfonyl fluoride. Lysates were clarified by centrifugation at 14,000 g at 4°C for 5 min and cell debris was discarded. SOD activity was detected using a commercial 'SOD Assay Kit' according to the manufacturer's protocol (Sigma) . Absorbance values at 450 nm were measured using a microplate reader. The experiment was repeated three times.
Serum cardiac markers
At the end of experimental period, rats were anesthetized with diethyl ether. Blood was collected by retro-orbital puncture and then the serum was separated. Serum levels of creatine kinase-MB isoenzyme (CK-MB) and lactate dehydrogenase (LDH) enzymes were measured by automated chemistry analyzer (Microlab 300, Merck) using reagent kits. Values of LDH and CK-MB were expressed in international units per liter (IU/L).
ELISA for detection of IL-1β, IL-6 and TNF-α in culture supernatant
H9c2 cells were cultured in 96-well plates. After the different indicated treatments, the levels of interleukin (IL)-1β, IL-6 and TNF-α in the culture media were tested by ELISA according to the manufacturer's instruction. The experiments were repeated five times.
Assay of ATP and ADP
ATP was measured based on bioluminescence generated from luciferin-luciferase reaction. The following reaction results in the generation of measurable light at a wavelength of 562 nm: ATP + luciferin + O 2 luciferase oxyluciferin + AMP + PP + CO + light (562 nm) Both intracellular ATP and ADP measurements were performed on H9c2 cardiac cells using the standard curve of ATP. Light emission was measured with a Sirius tube luminometer, Berthold Defection Systems (Germany). After calibration against the ATP standard, the ATP content of the cell lysate was determined. Then, ATP/ADP ratio was calculated.
In brief, the cells were pelleted in a microcentrifuge tube by centrifugation at 3000 g for 10 min. The cellular ATP was lysated by adding 0.5 mL water and boiling the cell pellet for 5 min. The sample was then vortexed and centrifuged (3000 g for 5 min at 4°C), 12 μL supernatant was used for bioluminescence measurement. About 12 μL of the supernatant was added to 25 μL cocktail (luciferin and Mg) and 10 μL of Tris buffer; 5 μL luciferase enzyme was added to the mixture and luminescence was read at 562 nm. Luminescence intensity correlated to ATP level in hepatocytes. For total ATP measurement, 12 μL supernatant was added to 5 μL MgCl 2 and 5 μL phosphoenolpyruvate and 12 μL phosphokinase. Phosphokinase changed the ADP to ATP. The mixture was incubated for 2 min and then 25 μL cocktail (luciferin and Mg) and 5 μL luciferase were added to the mixture and consequently luminescence was read at 562 nm. ADP level was calculated by calculating the difference between total ATP and primary ATP.
Histopathology
The tissues were from the left ventricle. After killing the rats, their hearts were fixed in 4% formaldehyde, embedded in paraffin and sectioned. Sections were stained with hematoxylin and eosin (H&E) and examined with microscope, and photographic images were captured.
Transmission electron microscopy
The tissues were from the left ventricle. Following the commencement of the experiment, selected samples of heart tissues from rats of each group were perfused with 0.9% NaCl at 37°C, and mixed with paraformaldehyde and 4% glutaraldehyde at 4°C. Then the samples were minced into small pieces (~2 mm) and successively fixed in 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.3) for 2 h. The specimens were then rinsed in buffer, postfixed in cacodylate-buffered 2% OsO 4 , stained in uranyl acetate, dehydrated gradiently in ethanol and embedded in epoxy resin by standard procedures. Finally, 50-70 nm superthin slices were obtained. The thin sections were stained with uranyl acetate and lead citrate and examined with a Philips TECNA10 electron microscope, and the photographic images were captured.
Statistical analysis
All data are presented as mean ± s.e.m. Differences between groups were analyzed by one-way (ANOVA by using (n = 5). **P < 0.01 vs with the control group; ++ P < 0.01 vs with the HG group, ‡ P < 0.01 vs with the HG + NRG group; HG, high glucose, 35 mM glucose; NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway.
SPSS 13.0 (SPSS) software, and followed by LSD post hoc comparison test. A value of P < 0.05 was considered to be significant.
Results
General features of control and diabetic rats
Diabetic rats displayed a significantly reduced body weight and heart weight index associated with hyperglycemia compared with control rats. Diabetes also exerted an effect on the serum B-type natriuretic peptide (BNP) and transforming growth factor (TGF)-β1 levels.
The fasting blood glucose level was markedly elevated in STZ-induced diabetic rats. The diabetes-induced changes in biometrics were significantly changed by NRG and PDTC treatment. All these results are shown in Table 1 .
NRG attenuates the hyperglycemia-induced expression of NF-κB p65 in vitro and in vivo
First, we observed the effects of HG (35 mM glucose) on NF-κB p65 phosphorylation (p) in vitro. H9c2 cells were exposed to HG for the indicated times (30, 60, 90, 120, 150 and 180 min) , and the expression level of p-NF-κB p65 (p-p65) was significantly upregulated, The data in (B-a and e) was quantified by densitometric analysis with Image J 1.47i software. Data are shown as the mean ± s.e.m. (n = 3). **P < 0.01 vs with the control group; + P < 0.05, ++ P < 0.01 vs with the HG group. HG, high glucose, 35 mmol/L glucose; NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway. White arrow: the abbreviation for nucleus.
reaching a peak at 90 min ( Fig. 1A and B) , while the total (t)-p65 expression was unchanged. The HG-induced p65 mRNA level was increased. Then, we tested the nuclear translocation of t-p65, as shown in Fig. 1E , F and G, and the expression level of total t-p65 in the cell nucleus was greater than in the cell cytoplasm, which suggested that NF-κB was activated and translocated to the nucleus from the cytoplasm in HG-induced cardiomyocytes.
Second, we tested the influence of NRG on the HG-induced activation of the NF-κB pathway. H9c2 cardiac cells were pretreated with 80 μM NRG for 2 h before exposure to HG for 24 h. As shown in Fig. 1C and D, the increased expression of p-p65 was significantly reduced by NRG pretreatment. Alone, NRG did not alter the basal expression level of p-p65 in H9c2 cells. Subsequently, we explored the effect of NRG on the nuclear translocation of the NF-κB p65 subunit. NRG pretreatment significantly ameliorated the HG-induced nuclear translocation ( Fig. 1E and G), with increasing amounts of NF-κB p65 in the cytosol (Fig. 1E and F) . Furthermore, we found that NRG inhibited the p65 mRNA level. These results suggested that NRG inhibited NF-κB activation by blocking the HG-induced phosphorylation and nuclear translocation of p65 subunit.
In STZ-induced diabetic rats, the expression levels of p-p65 and p65 mRNA were markedly increased. The treatment of STZ-induced diabetic rats with NRG (L-NRG, M-NRG and H-NRG) or PDTC also markedly suppressed the STZ-induced increased expression level of p-p65 and the p65 mRNA level (Fig. 1H, I , J and K).
NRG and PDTC attenuate the hyperglycemia-induced decreased expression of the K ATP channel protein in vitro and in vivo
As indicated in Fig. 2A , B, C and D, H9c2 cells were exposed to 35 mM glucose for 12 h, and the expression level of the K ATP channel protein was obviously reduced. Importantly, the decreased expression of the K ATP channel was ameliorated by the pretreatment of the cells with 80 µM NRG for 2 h or 100 µM PDTC for 30 min before exposure to HG for 12 h. However, the basal expression level of the K ATP channel was not changed by separate treatment with 80 µM NRG for 2 h or 100 µM PDTC for 30 min. It was shown that the blockade of K ATP channels with 5-HD or Gli markedly reversed the increased effect of NRG and PDTC against (n = 3). **P < 0.01 vs with the control group; ++ P < 0.01 vs with the HG group. HG, high glucose; NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway.
the HG-induced decreased expression of K ATP channel proteins (Fig. 2B) . Similarly, compared with the control group, the expression level of the K ATP channel protein was obviously reduced in STZ-induced diabetic rats. However, the STZ-induced decreased expression level of K ATP channel proteins increased to different degrees in the STZ + L-NRG group, STZ + M-NRG group, STZ + H-NRG group and STZ + PDTC group. These data indicated that NRG and PDTC alleviated the decrease in the expression level of K ATP channels induced by HG in H9c2 cardiac cells.
Furthermore, we observed the effects of HG (35 mM glucose) on the ADP/ATP ratio in vitro. H9c2 cells were exposed to HG for 2 h, and the ADP/ATP ratio was significantly upregulated (Fig. 2G) . However, the upregulated ADP/ATP ratio was markedly repressed by pretreatment with 80 µM NRG for 2 h or 100 µM PDTC for 30 min before exposure to HG. Alone, NRG or PDTC did not affect the ADP/ATP ratio of H9c2 cardiac cells.
The NF-κB pathway and K ATP channels are involved in the protective effect of NRG against HG-induced cardiomyocyte cytotoxicity in H9c2 cardiac cells
As shown in Fig. 3A , the exposure of H9c2 cells to HG for 24 h obviously induced cytotoxicity, which led to a decrease in cell viability. However, the decreased cell viability was markedly repressed by pretreatment with 80 µM NRG for 2 h or 100 µM PDTC for 30 min before exposure to HG. Alone, NRG or PDTC did not affect the viability of H9c2 cardiac cells.
To explore the role of K ATP channels in HG-induced cytotoxicity, the cells were treated with 100 µM DZ or 50 µM Pin for 30 min before exposure to HG. As shown in Fig. 3B , pretreatment of H9c2 cardiac cells with DZ or Pin considerably mitigated the HG-induced cytotoxicity, as evidenced by an increase in cell viability. To further investigate the role of K ATP channels in the protective effect of NRG against HG-induced cytotoxicity, the cells were treated with 100 µM 5-HD or 1 mM Gli for 30 min before exposure to NRG and HG. It was shown that the blockade of K ATP channels with 5-HD or Gli markedly reversed the protective effect of NRG against the HG-induced cytotoxicity, which resulted in a decrease in cell viability (Fig. 3B) . Alone, 5-HD or Gli did not significantly alter the cell viability. These data suggested that K ATP channels mediated the anticytotoxicity of NRG in the HG-treated H9c2 cardiac cells.
NRG and PDTC suppress hyperglycemia-induced cardiomyocyte apoptosis in vitro and in vivo
In Fig. 4A-b and g, exposure of H9c2 cells to 35 mM glucose for 24 h induced typical apoptosis, which was manifested (n = 3). **P < 0.01 vs with the control group; ++ P < 0.01 vs with the HG-treated group. NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway.
as the nuclear condensation and fragmentation condensation of chromatin and the shrinkage of nuclei and apoptotic bodies. However, pretreatment of the cells with 80 µM NRG for 2 h of HG exposure obviously mitigated the HG-induced increase in the number of cells that underwent apoptosis (Fig. 4A-c and d) . In addition, preconditioning of the cells with 100 µM PDTC for 30 min before exposure to HG also ameliorated HG-induced apoptosis of cardiac cells (Fig. 4A-d and g ). Alone, NRG (Fig. 4A-e and g ) or PDTC (Fig. 4A-f and g ) did not significantly change the number of apoptotic H9c2 cells. Similarly, both in HG-induced H9c2 cardiac cells and in STZ-induced rats, the expression levels of cleaved caspase-3 and bax were markedly enhanced, and
Figure 7
Naringin and PDTC alleviate hyperglycemiainduced production of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α) in vitro and in vivo. The cells were treated with 35 mM glucose for 24 h with or without preconditioned with 80 μM NRG for 2 h or 100 μM PDTC. The SD rats were treated with or without 30 mg/kg/day STZ or 25, 50 or 100 mg/kg/day NRG or 100 mg/ kg/day PDTC. Enzyme-linked immunosorbent assay (ELISA) was performed to determine the levels of (A and B) IL-1β, (C and D) IL-6, and (E and F) TNF-α in cell supernatants. Data are shown as the mean ± s.e.m. (n = 5). **P < 0.01 vs the control (Con) group; ++ P < 0.01 vs the HG-treated group.
the expression level of bcl-2 was decreased. However, the increased expression levels of cleaved caspase-3 and bax were attenuated by pretreatment with 80 µM NRG for 2 h or 100 µM PDTC for 30 min (STZ + NRG treatment rats or PDTC treatment rats, respectively), and the decreased expression level of bcl-2 was upregulated. Alone, NRG or PDTC did not significantly affect the basal expression level of cleaved caspase-3, bax and bcl-2.
NRG and PDTC diminish HG-induced increased oxidative stress in H9c2 cardiac cells
This study demonstrated that oxidative stress contributed to HG-induced cardiomyocyte injury (Chen et al. 2014a,b) . As shown in Fig. 5 , exposure of H9c2 cells to 35 mM glucose for 24 h markedly induced oxidative stress, as evidenced by an increase in the generation of ROS (Fig. 5A-b and g ), a decrease in the SOD activity (Fig. 5B) and an increased expression level of Nox4 (Fig. 5C) . However, pretreatment of the cells with 80 µM NRG for 2 h before HG exposure obviously mitigated the HG-induced increase in ROS generation (Fig. 5A-c and  g ), increased the HG-induced decrease in SOD activity (Fig. 5B) and decreased the expression level of Nox4 (Fig. 5C ). To test whether the NF-κB signaling pathway is involved in HG-induced oxidative stress, H9c2 cells were pretreated with 100 µM PDTC for 30 min before exposure to HG. Our data showed that pretreatment with PDTC Figure 8 The effects of naringin and PDTC on heart tissues changes of STZ-induced diabetic rats. (200×: A→F, 400×: G→L). A and G: Control group; B and H: STZ-induced diabetic rats group; C and I: STZ + L-NRG group, STZ-induced diabetic rats treatment with low-dose NRG; D and J: STZ + M-NRG group, STZ-induced diabetic rats treatment with middle-dose NRG; E and K: STZ + H-NRG group, STZ-induced diabetic rats treatment with high-dose NRG; F and L: STZ + PDTC group, STZ-induced diabetic rats treatment with PDTC. STZ, streptozotocin; NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway.
considerably diminished the generation of ROS (Fig. 5A-d  and g ), upregulated SOD activity (Fig. 5B ) and inhibited Nox4 expression (Fig. 5C) . NRG or PDTC treatment alone did not change the basal level of ROS, SOD activity and Nox4 expression in H9c2 cells.
NRG and PDTC block the HG-induced dissipation of MMP in H9c2 cells
As with oxidative stress, mitochondrial damage has been shown to be involved in HG-induced cardiomyocyte injury (Chen et al. 2014a ,b, Xu et al. 2015 . It was shown that exposure of the cells to 35 mM glucose for 24 h elicited mitochondrial damage, as manifested by the dissipation of MMP (Fig. 6B and G) . The dissipation of MMP was reduced by pretreatment of the cells with 80 µM NRG for 2 h before exposure to HG (Fig. 6C and G) , which showed that NRG protected H9c2 cells against HG-induced mitochondrial damage. Similarly, the pretreatment of cardiomyocytes with 100 µM PDTC for 30 min before exposure to HG similarly attenuated the HG-induced dissipation of MMP (Fig. 6D and G) . The effects of NRG and PDTC on ultrastructure changes of STZ-induced diabetic rats heart tissues (5800×: A→F, 13,500×: G→L). A and G: Control group; B and H: STZ-induced diabetic rats group; C and I: STZ + L-NRG group, STZ-induced diabetic rats treatment with low-dose NRG; D and J: STZ + M-NRG group, STZ-induced diabetic rats treatment with middle-dose NRG; E and K: STZ + H-NRG group, STZ-induced diabetic rats treatment with high-dose NRG; F and L: STZ + PDTC group, STZ-induced diabetic rats treatment with PDTC. STZ, streptozotocin; NRG, naringin; PDTC, pyrrolidine dithiocarbamate, a specific inhibitor of NF-κB pathway. Black arrow: swollen mitochondria, white arrow: vacuolar mitochondria.
NRG and PDTC suppress the hyperglycemia-induced production of pro-inflammatory cytokines by inhibiting the NF-κB pathway in H9c2 cardiac cells and in STZ-induced diabetic rats
As shown in Fig. 7 , the levels of IL-1β (Fig. 7A and B) , IL-6 (Fig. 7C and D) and TNF-α (Fig. 7E and F) were markedly increased in hyperglycemia-induced H9c2 cardiac cells and in STZ-induced diabetic rats compared with the control group (P < 0.01). However, these increased levels of IL-1β, IL-6 and TNF-α were significantly suppressed by treatment with NRG, which suggested an inhibitory effect of NRG on the production of pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α, induced by hyperglycemia. Similarly, the treatment of H9c2 cells with PDTC, a specific inhibitor of the NF-κB pathway, depressed the enhanced production of IL-1β, IL-6 and TNF-α.
The effects of NRG and PDTC on structural changes of the heart tissues of STZ-induced diabetic rats by H&E staining H&E staining of the heart tissues showed that compared with the control group, diabetic hearts displayed structural abnormalities, such as the degeneration of cardiac myofibrils, a marked separation of myocardial fibers from each other, and hemorrhagic areas ( Fig. 8B and H). These structural abnormalities in the heart of STZ diabetic animals were at least partially prevented by L-NRG ( Fig. 8C and I ), M-NRG ( Fig. 8D and J) , H-NRG ( Fig. 8E and K) or PDTC ( Fig. 8F and L) treatment.
The effects of NRG and PDTC on ultrastructural changes in the heart tissues of STZ-induced diabetic rats by transmission electron microscopy analysis
The myocardial structure was examined by transmission electron microscopy. In the control group, well-organized, typical symmetric myofibrils and packed mitochondria beside the fibers were observed, the mitochondria were oval in shape, the ridge was closely spaced with the intact membrane, and the gap junctions were visible and dense. The STZ-induced diabetic rat heart tissues showed loss and damage of myofibrils compared with the control group, along with a significantly decreased volume of myofibrils. As shown in Fig. 9B , the mitochondria were swollen, fragmented, distended and clumped, and the cristae in the mitochondria were distorted or completely lysed. In addition, some disks were distorted and ruptured. After treatment with 25 mg/kg/day NRG (low-dose NRG) (Fig. 9C and L) , 50 mg/kg/day NRG (middle-dose NRG) ( Fig. 9D and J) , 100 mg/kg/day NRG (high-dose NRG) ( Fig. 9E and K) or 100 mg/kg/day PDTC (Fig. 9D) , the STZ-induced diabetic rats exhibited improved cardiac structure. The damage to myofibrils was reversed, and the volume percentage of myofibrils was increased. The swelling, fragmentation, distension and clumping of mitochondria were suppressed, and the number of STZ-induced injuries in mitochondria was also decreased. There was limited rupture or dissolution of the fibrin in the sarcomere, and the cross-connections of the intercalated disk were also clear.
Discussion
In this study, we demonstrate that the NF-κB pathway, which regulates cardiac cell apoptosis, oxidative stress, mitochondrial damage, the production of pro-inflammatory cytokines, myocardial hypertrophy, myocardial remodeling and cardiac fibrosis in DM, is a crucial regulatory mechanism for the development of DCM. Otherwise, K ATP has an important role in the HG-induced injury of H9c2 cardiac cells. More importantly, we provide new insight into the mechanisms responsible for the cardioprotection of NRG against hyperglycemia-induced cardiac cell injuries by inhibiting the activation of NF-κB pathway in vitro and in vivo and upregulating K ATP channels in vitro.
In this study, p65 was our target to test the effect of the NF-κB pathway in STZ-induced diabetic rats and in HG-induced injuries to H9c2 cardiac cells. Similar to previous studies (Valen et al. 2001 , Fang et al. 2004 , Eisner et al. 2006 , Westermann et al. 2007a ,b, Mariappan et al. 2010 , Arkan & Greten 2011 , our findings showed that hyperglycemia could increase the expression level of p-NF-κB p65 (Fig. 1) . Furthermore, NF-κB was activated and dissociated from IκB and released and translocated into the nucleus from the cytoplasm, which led to an increase in the expression level of nuclear (nuc) p65 (Fig. 1) . This allowed NF-κB (p65) to bind to κB sequences in DNA and alter the expression of various target genes (Rajadurai & Prince 2009 ). These results strongly indicated that the NF-κB pathway was activated and might be involved in the pathogenesis of DCM. In our present research, we found that the NF-κB pathway was involved in hyperglycemiainduced cytotoxicity (Fig. 3A) , apoptosis (Fig. 4) , oxidative stress (Fig. 5) , dissipation of MMP (Fig. 6) , inflammation ( Fig. 7) and myocardial remodeling (Figs 8 and 9 ). These findings demonstrated that the activation of NF-κB plays a crucial role in the development of DCM in diabetic patients by controlling different set of genes and participating in the related processes. Moreover, cardiac K ATP channels are very important for the metabolic status of cardiomyocytes as key sensors and effectors, and their roles in the HG-induced cardiomyocyte injury have conspicuously attracted attention. First, in this study, our data showed that exposure of the cardiac cells to HG prominently reduced the expression level of K ATP channels, which suggested that K ATP channels may be involved in the progress of HG-induced cardiac cell injuries. A recent study indicated that a reduction in number of sarcolemmal K ATP channels affects cardiac action potentials under hypoxia (Zhu et al. 2011) ; therefore, we hypothesized that the inhibition of cardiac K ATP channels might be a pivotal mechanism underlying HG-induced cardiomyocyte injury. To confirm our hypothesis, we secondarily observed the influence of K ATP channel activation on HG-induced injury. In agreement with our recent studies (Zhu et al. 2011 , Chen et al. 2014a , the findings of this study showed that treatment of H9c2 cardiac cells with HG induced considerable injuries, including a decrease in cell viability. However, pretreatment of H9c2 cardiac cells with DZ or Pin markedly attenuated the HG-induced injuries, as evidenced by an increase in cell viability. The above results suggest that HG impairs the function of cardiac K ATP channels, which contributes to HG-induced injuries. Thus, the above results strongly suggested that NF-κB and K ATP channels might play critical roles in the pathogenesis of DCM.
An important finding of this study relates to the cardioprotection of NRG in hyperglycemia-induced insults in vitro and in vivo. First, consistent with the previously reported results (Huang et al. 2013) , we found that NRG markedly suppressed HG-triggered cytotoxicity and apoptosis, and it was suggested that NRG contributed to cardioprotection by attenuating mitochondrial dysfunction and inhibiting the activation of the p38 MAPK pathway. Our results are supported by a series of previous studies (Jagetia et al. 2003 , Kanno et al. 2003 . Second, we observed that NRG could exert remarkable antihyperglycemic effects (Table 1) in STZ-induced diabetic rats. Its mechanism has multiple components: (i) NRG activates glutathione (GSH) synthesis through a novel antioxidant defense mechanism against excessive ROS production, which contributes to the prevention of oxidative damage in addition to its effect on glycemic control (Dhanya et al. 2015) ; (ii) NRG plays important roles in preventing the progression of hyperglycemia, partly by binding to starch by increasing hepatic glycolysis and the glycogen concentration and lowering hepatic gluconeogenesis (Shen et al. 2012) ; (iii) NRG exhibits antidiabetic effects in a rat model of type 2 diabetes mellitus (T2DM) by potentiating the antioxidant defense system and suppressing pro-inflammatory cytokine production (Mahmoud et al. 2012) . Third, this study demonstrates the inhibitory effect of NRG on myocardial remodeling and cardiac fibrosis in STZinduced diabetic rats by inhibiting the NF-κB pathway. Fourth, our study shows the inhibitory effect of NRG on hyperglycemia-induced NF-κB activation. Currently, the effects of NRG against hyperglycemia-induced cardiac injury in DM have attracted considerable attention due to its cardioprotective effect (Kanno et al. 2004 , Rajadurai & Prince 2007 ). Our more recent study showed that NRG could protect cardiomyocytes against HG-induced injuries by inhibiting the activation of MAPKs (Jung et al. 2003) and the leptin-p38 MAPK (Chen et al. 2014a,b) pathway in H9c2 cells. However, the mechanisms underlying the effect of NRG on the NF-κB pathway remain unclear. Thus, this study explored the effect of NRG on the activation of the NF-κB pathway in HG-treated H9c2 cardiac cells and in STZ-induced diabetic rats. As in our previous study , NRG considerably suppressed the expression levels of p-p65, which suggested that NRG could inhibit the hyperglycemia-induced activation of NF-κB in vitro and in vivo. These results suggested that the NF-κB pathway might play a critical role in the cardioprotection of NRG.
However, the protective mechanisms of NRG are complicated, and other factors may also be involved in the cardioprotection of NRG. Interestingly, the results of this study relate to the role of the activation of K ATP channels in the cardioprotective effects of NRG against HG-induced cardiac injuries. Our results demonstrated that NRG markedly reduced the downregulation of K ATP channel expression by HG and that both 5-HD and Gli significantly blocked the cardioprotective effect of NRG mentioned above. These results suggested that K ATP channels, particularly the mitochondrial K ATP channels, might play a critical role in the cardioprotection of NRG.
In this study, we also investigated the relationship between the NF-κB pathway and cardiac K ATP channel activation. As mentioned above, PDTC, an inhibitor of the NF-κB pathway, markedly blocked a decrease in the expression of K ATP channel proteins induced by HG. Collectively, these results revealed that K ATP channels might be a downstream molecule of the NF-κB pathway in HG-treated cardiac cells. Elucidating the molecular mechanism underlying this interaction may be significant in the treatment and prevention of DM-related DCM.
Exposing H9c2 cells to HG for 12 h markedly decreased the expression level of K ATP channel proteins and increased the ADP/ATP ratio. An increase in the ATP/ADP ratio closes K ATP channels (which leads to depolarization), whereas a decrease in the ATP/ADP ratio opens K ATP channels (which leads to hyperpolarization) (Sun & Feng 2013) . These changes suggest that HG both opened and inhibited the expression level of K ATP channels. It is difficult to explain this phenomenon. Its potential mechanism requires further research. Therefore, the above findings showed that the activation of NF-κB is involved in hyperglycemia-induced cytotoxicity, apoptosis, ROS production, the dissipation of MMP, myocardial remodeling and myocardial fibrosis in vitro and in vivo. HG impairs the function of cardiac K ATP channels, which contribute to HG-induced injuries. Our results revealed that the inhibitory effect of NRG on the activation of NF-κB might be one of the important mechanisms responsible for its protection against hyperglycemia-induced injuries in H9c2 cardiac cells and in STZ-induced type 2 diabetic rats.
Conclusions
In conclusion, our study demonstrated that NRG, which could protect cardiomyocytes against hyperglycemiainduced injury in vivo and in vitro, had antimitochondrial, anti-oxidant, anti-apoptosis, anti-inflammatory and antifibrosis activities at least partially by inhibiting the NF-κB pathway and upregulating K ATP channels. These results also raise the possibility that NRG may be a potential candidate in the prevention and treatment of diabetic vascular complications at an appropriate dosage.
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